Skip to content

Integra LifeSciences IART Restructuring Reserve

Restructuring Reserve at other companies

ITG
Integer HoldingsITGR
$195K-53.5%
ICU Medical logo
ICU MedicalICUI
$5.53M-42.6%
Henry Schein logo
Henry ScheinHSIC
$34M-19.0%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$0
STERIS logo
STERISSTE

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:RestructuringReserve.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's restructuring reserve.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's restructuring reserve?
Integra LifeSciences (IART) reported restructuring reserve of $8.75M in Q1 2026.
How has Integra LifeSciences's restructuring reserve changed year-over-year?
Integra LifeSciences's restructuring reserve decreased by 7.1% year-over-year, from $9.42M to $8.75M.
What is the long-term trend for Integra LifeSciences's restructuring reserve?
Over 3 years (2021 to 2025), Integra LifeSciences's restructuring reserve has grown at a 1.8% compound annual growth rate (CAGR), from $10.23M to $10.77M.
What does restructuring reserve mean?
This represents the estimated liability for costs associated with formal restructuring plans, such as severance, facility closures, or asset impairments. It reflects management's commitment to operational efficiency and strategic realignment. These reserves are drawn down as the restructuring activities are executed.